ADIPOQ and type 1 diabetes mellitus: Our study found that ADIPOQ was upregulated in the ≤ 6-year-old T1D-1 subgroup and downregulated in the > 6-year-old T1D-2 subgroup, suggesting age-dependent variation in expression among our pediatric T1D subgroups, potentially reconciling the discrepancies across previous studies.